14-day Premium Trial Subscription Sign Up For FreeGet Free

Arrowhead Research Corporation Stock Forecast NASDAQ:ARWR

Price Target and Analyst Ratings

Most Recent Rating

On August 10, 2021 "HC Wainwright" gave "$95.00 - $100.00" rating for ARWR. The price target was changed from $62.78 to 3.1%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-10 $95.00 - $100.00 Target Raised by HC Wainwright $61.21 $62.78→3.1%
2021-08-06 $94.00 - $97.00 Target Raised by Chardan Capital $64.79 $68.05+2.9%
2021-08-06 $97.00 - $94.00 Target Lowered by Chardan Capital $64.79 $68.05+2.9%
2021-07-02 Buy Reiterated by HC Wainwright $63.13 $95.00
2021-07-02 Buy Reiterated by Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell $63.13 $95.00
2021-07-02 Overweight Target Lowered by Piper Sandler $63.13 $109.00 → $89.00
2021-06-27 Hold Reiterated by SVB Leerink $90.32
2021-06-21 Overweight - Overweight Target Raised by Piper Sandler $89.81 $99.00 → $109.00
2021-02-08 Buy Target Raised by B. Riley $88.41 $98.00 → $106.00
2021-02-08 Target Raised by Citigroup $88.41 $90.00 → $110.00
2021-02-08 Buy Reiterated by B. Riley $88.41 $98.00 → $106.00
2021-02-05 Overweight Target Raised by Piper Sandler $90.47 $90.00 → $99.00
2021-02-05 Buy Target Raised by HC Wainwright $90.47 $90.00 → $95.00
2021-02-05 Buy Target Raised by Chardan Capital $90.47 $81.00 → $97.00
2021-02-05 Buy Reiterated by HC Wainwright $90.47 $90.00 → $95.00
2020-12-21 Outperform - Neutral Downgraded by Robert W. Baird $82.03 $75.00
2020-12-15 Buy Initiated by UBS Group $76.45
2020-11-24 Positive - Outperform Target Raised by Royal Bank of Canada $60.39 $62.00 → $80.00
2020-11-24 Overweight Target Raised by Cantor Fitzgerald $60.39 $58.00 → $80.00
2020-11-24 Market Perform Target Lowered by SVB Leerink $60.39 $35.00 → $34.00
2020-11-19 Buy Initiated by Smith Barney Citigroup $68.92 $90.00
2020-11-19 Buy Initiated by Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell $68.92 $90.00
2020-11-17 Buy - Positive Target Raised by B. Riley $70.79 $68.00 → $98.00
2020-11-16 Outperform Target Raised by Robert W. Baird $69.07 $70.00 → $75.00
2020-10-12 Target Raised by B. Riley $46.39 $57.00 → $68.00
2020-10-12 Buy Reiterated by HC Wainwright $46.39
2020-10-08 Target Raised by Piper Sandler $48.01 $80.00 → $90.00
2020-09-17 Market Perform Target Raised by SVB Leerink $45.75 $29.00 → $31.00
2020-07-29 Buy Reiterated by Chardan Capital $44.30 $81.00
2020-05-12 Outperform Initiated by Royal Bank of Canada $35.94
2020-05-08 Market Perform - Outperform Upgraded by Oppenheimer $34.14 $58.00
2020-05-08 Buy Reiterated by Cantor Fitzgerald $34.14 $60.00 → $58.00
2020-04-15 Neutral - Overweight Upgraded by Cantor Fitzgerald $35.33 $55.00 → $60.00

ARWR Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -18.60% during the next 3 months and, with a 90% probability hold a price between $42.91 and $60.56 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $52.44 $63.28 $74.13
2021-09-23 $52.17 $63.01 $73.86
2021-09-24 $51.90 $62.74 $73.59
2021-09-27 $51.63 $62.47 $73.32
2021-09-28 $51.36 $62.20 $73.05
2021-09-29 $51.09 $61.93 $72.78
2021-09-30 $50.82 $61.66 $72.51
2021-10-01 $50.55 $61.39 $72.24
2021-10-04 $50.28 $61.12 $71.97
2021-10-05 $50.01 $60.85 $71.70
2021-10-06 $49.74 $60.58 $71.43
2021-10-07 $49.47 $60.31 $71.16
2021-10-08 $49.20 $60.04 $70.89
2021-10-11 $48.93 $59.77 $70.62
2021-10-12 $48.66 $59.51 $70.35
2021-10-13 $48.39 $59.24 $70.08
2021-10-14 $48.12 $58.97 $69.81
2021-10-15 $47.85 $58.70 $69.54
2021-10-18 $47.58 $58.43 $69.27
2021-10-19 $47.31 $58.16 $69.00
2021-10-20 $47.04 $57.89 $68.73
2021-10-21 $46.77 $57.62 $68.46
2021-10-22 $46.50 $57.35 $68.19
2021-10-25 $46.23 $57.08 $67.92
2021-10-26 $45.96 $56.81 $67.65
2021-10-27 $45.69 $56.54 $67.38
2021-10-28 $45.42 $56.27 $67.11
2021-10-29 $45.15 $56.00 $66.84
2021-11-01 $44.88 $55.73 $66.57
2021-11-02 $44.61 $55.46 $66.30

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops novel drugs to treat intractable diseases in the United States. The company utilizes its proprietary Dynamic Polyconjugate platform to develop targeted drugs based on the RNA interference mechanism that silences disease-causing genes. Its ARC-520, an RNAi-based therapeutic that is in Phase IIb clinical efficacy studies to treat chronic hepatitis B virus infection; and ARC-AAT,... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT